FTO and gastric cancer: Our study uncovered a significant suppressive role for FTO in EBVaGC metastasis and invasiveness through a series of in vitro and in vivo experiments and showed that FTO expression was associated with better prognosis in GC patients, suggesting that FTO might be a biomarker for predicting the metastasis and outcome of GC patients.